z-logo
Premium
Prospects for flavonoid and related phytochemicals as nature‐inspired treatments for C lostridium difficile infection
Author(s) -
Wu X.,
Alam M.Z.,
Feng L.,
Tsutsumi L.S.,
Sun D.,
Hurdle J.G.
Publication year - 2014
Publication title -
journal of applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 1364-5072
DOI - 10.1111/jam.12344
Subject(s) - library science , clostridium difficile , medicine , biology , microbiology and biotechnology , computer science , antibiotics
Aims There is a need for novel treatments for C lostridium difficile infection ( CDI ). Antibacterial flavonoids are part of a large family of polyphenol phytochemicals with a long history of use in ethnomedicine, but are unexamined against Cl .  difficile . We explored their anti‐difficile properties. Methods and Results Anti‐difficile activities were determined for several naturally occurring flavonoids, olympicin A and synthetic 4‐chromanone and chalcone analogues. With the exception of olympicin A, most naturally occurring phytochemicals tested were poorly active. Diversified synthetic flavonoids resembling olympicin A retained anti‐difficile activity, suggesting olympicin A could act as a pharmacophore to obtain novel agents. They also demonstrated concentration‐dependent killing of logarithmic and stationary phase cultures and reduced sporulation and toxin production. Olympicin A and some synthetic flavonoids dissipated the bacterial transmembrane potential. Interestingly, mutants could only be selected with the analogue 207 at a frequency of 10 −9 . Conclusions Based on the potent anti‐difficile properties of olympicin A and modified flavonoids, further exploration of this class of phytochemicals is warranted. Significance and Impact of the Study C lostridium difficile infection is a major problem in developed countries. These studies point to there being an avenue for optimizing plant‐derived flavonoids, and related antibacterial phytochemicals, as nature‐inspired approaches to treat CDI .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom